Stock comparison
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$104.98BHealthcare Market cap, Sector
SI-BONE
SIBN$804.5MHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO 70 SIBN
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
SANOFICONR.BO7wins
0winsSIBN
78B
F37
89A
D56
83B
D55
77B
F40
91A
F2
86A
F38
85A
F37
Side-by-side metrics
| Metric | SANOFICONR.BO | SIBN |
|---|---|---|
| Market cap | Winner: $104.98B | $804.5M |
| P/E (TTM) | 44.0x | - Winner |
| EV/EBIT | 31.7x | - Winner |
| ROIC (TTM) | Winner: 59.15% | -8.99% |
| Gross margin | 68.13% | 79.59% Winner |
| Net margin | Winner: 27.35% | -8.1% |
| Revenue CAGR 5y | Winner: 27.01% | 22.18% |
| EPS CAGR 5y | 20.67% | - |
| Debt / Equity | 0.1x | 0.0x Winner |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
SANOFICONR.BO leads on
- Net margin27.35%vs -8.1%+130%
- ROIC (TTM)59.15%vs -8.99%+115%
- Market cap$104.98Bvs $804.5M+99%
- Revenue CAGR 5y27.01%vs 22.18%+18%
SIBN leads on
- EV/EBIT-vs 31.7x+185%
- P/E (TTM)-vs 44.0x+185%
- Debt / Equity0.0xvs 0.1x+36%
- Gross margin79.59%vs 68.13%+14%
More like SANOFICONR.BO
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.